2023 annual financial data
Lisata Therapeutics 2023 Operating margin
Lisata Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -25,708,000 USD and net income was -20,840,000 USD.
Operating cash flow was -20,032,000 USD.
Get free Lisata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -25,708,000 USD
- Net income
- -20,840,000 USD
- Operating cash flow
- -20,032,000 USD